Stocks and Investing Stocks and Investing
Wed, January 24, 2024
Tue, January 23, 2024

Robert Burns Maintained (BNTX) at Strong Buy with Decreased Target to $107 on, Jan 23rd, 2024


Published on 2024-10-28 08:30:09 - WOPRAI, Robert Burns
  Print publication without navigation


Robert Burns of HC Wainwright & Co., Maintained "BioNTech SE" (BNTX) at Strong Buy with Decreased Target from $133 to $107 on, Jan 23rd, 2024.

Robert has made no other calls on BNTX in the last 4 months.



There are 3 other peers that have a rating on BNTX. Out of the 3 peers that are also analyzing BNTX, 2 agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Korn of "Morgan Stanley" Maintained at Hold with Increased Target to $111 on, Wednesday, November 8th, 2023
  • Yifeng Liu of "HSBC" Downgraded from Strong Buy to Hold and Decreased Target to $111 on, Monday, October 16th, 2023


This is the rating of the analyst that currently disagrees with Robert


  • Jessica Fye of "JP Morgan" Downgraded from Hold to Sell and Decreased Target to $99 on, Friday, December 1st, 2023

Contributing Sources